Wei Zhang

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in Extracorporeal Blood Treatment. Top assignee: Fresenius Medical Care Deutschland Gmbh. Active years: 2003-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Zhang. Retrieved from https://idiyas.com/inventor/wei-zhang-nkokjqxp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 72.2

CIPO Patents = 3

EPO Patents = 16 (Patent Applications = 14)

Average Co-Inventor Count = 1.6

ph-index = 9

Forward Citations = 196(Granted Patents)

Location History:

Schweinfurt, DE (2003)
Niederwerm, DE (2008 - 2012)
Niederwerrn, DE (2010 - 2022)

Company Filing History:

18 out of 890

Fresenius Medical Care Deutschland Gmbh

patents

Years Active: 2003-2022

Loading Chart...

Areas of Expertise:

Extracorporeal Blood Treatment

Dialysis Machine

Blood Parameter Monitoring

Vascular Stiffness

Blood Flow Correction

Hematocrit Measurement

Blood Volume Determination

Recirculation Analysis

Substitution Fluid Supply

Pulse Transit Time

Blood Constituent Measurement

Medical Treatment Units

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11529450 - Device for extracorporeal blood treatment having an evaluation and control unit (2022-12-20),

2. 11241524 - Dialysis machine and method of correcting the blood flow value (2022-02-08),

3. 10744256 - Method for determining at least one parameter of an extracorporeal blood circuit as well as apparatuses (2020-08-18),

4. 10016138 - Method and device for long-term monitoring of arterial vascular stiffness and vascular calcification of a patient (2018-07-10),

5. 9878081 - Arrangement comprising medical treatment units and peripheral devices as well as a peripheral device and treatment unit for use in such an arrangement (2018-01-30),

6. 9849228 - Method for determining at least one parameter of an extracorporeal blood circuit as well as apparatuses (2017-12-26),

7. 9814412 - Method and device for determining a blood constituent (2017-11-14),

8. 9265872 - Device and method for measuring a blood constituent in blood for an extracorporeal blood treating device (2016-02-23),

9. 9050420 - Device and method for monitoring a vascular access for an extracorporeal blood treatment (2015-06-09),

10. 8858486 - Method and arrangement for determining the recirculation in a fistula or the cardiopulmonary recirculation, and a blood treatment device comprising a device for determining the fistula recirculation or the cardiopulmonary recirculation part (2014-10-14),

11. 8792089 - Device for determining a concentration of a constituent of blood in a hose line (2014-07-29),

12. 8773649 - Device for clamping a hose line for determining the concentration of a blood constituent (2014-07-08),

13. 8529767 - Method for determining the percentage of recirculation in a fistula and/or cardiopulmonary recirculation relative to the total fistula recirculation and cardiopulmonary recirculation (2013-09-10),

14. 8303807 - Dialyser with measuring devices for monitoring the blood pressure, method of determining the blood pressure and a storage medium for use in a dialyser (2012-11-06),

15. 7850856 - Method and device for monitoring the supply of substitution fluid during an extracorporeal blood treatment (2010-12-14),

Title: Wei Zhang: The Visionary Inventor Shaping the Future of Medical Technology

Introduction: Wei Zhang, a brilliant inventor based in Niederwerrn, Germany, has made a significant impact on the world of technology with his innovative creations. His relentless pursuit of excellence and passion for innovation have solidified his reputation as a visionary in the field of medical technology.

Latest Patents: With an impressive portfolio of 18 patents, Wei Zhang continues to push the boundaries of medical innovation. His latest patents include a "Device for extracorporeal blood treatment having an evaluation and control unit" and a "Dialysis machine and method of correcting the blood flow value." These inventions showcase his expertise and dedication to improving healthcare practices.

Career Highlights: Wei Zhang is currently employed at Fresenius Medical Care Deutschland GmbH, a leading healthcare company known for its groundbreaking medical solutions. His work at Fresenius has been instrumental in advancing the field of extracorporeal blood treatment, demonstrating his commitment to enhancing patient care and treatment outcomes.

Collaborations: Throughout his career, Wei Zhang has collaborated closely with talented individuals such as Christoph Bardorz and Elke Schulte. These collaborative efforts have resulted in the development of groundbreaking technologies that have changed the landscape of medical technology.

Conclusion: Wei Zhang's passion for innovation and his commitment to excellence continue to drive his success as a visionary inventor. His contributions to the field of medical technology are nothing short of remarkable, and his inventive spirit serves as a beacon for future innovators seeking to shape the future of healthcare.

Profile summary based on public USPTO records.